Different Molecular Mechanisms Leading to White Matter Hypomyelination in Infantile Onset Lysosomal Disorders

Hypomyelinating leukoencephalopathies may be related to a primary disturbance in the formation of myelin or may be caused by neuronal, oligodendrocytic or astrocytic dysfunction, leading to a failure of myelination. Abnormal myelination related to a direct metabolic damage on oligodendrocytes has been shown to occur in some animal models of lysosomal storage diseases. To demonstrate that cerebral white matter hypomyelination may occur also in humans affected by early-onset lysosomal storage diseases, we report three cases with infantile-onset lysosomal storage disorders (type 1 GM1 gangliosidosis, globoid cell leukodystrophy or Krabbe's disease, and type A Niemann-Pick disease) showing white matter hypomyelination. Hypomyelinating leukoencephalopathy may therefore represent a feature of lysosomal storage disorders with onset in the first months of life, when the process of myelination is particularly active, indicating that neuronal storage disorders may be primarily responsible for central nervous system hypomyelination.

[1]  E. Richfield,et al.  EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy , 2005, Nature Medicine.

[2]  W. Kamphorst,et al.  The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction , 2004, Acta Neuropathologica.

[3]  R. Folkerth,et al.  Infantile GM1 Gangliosidosis: Complete Morphology and Histochemistry of Two Autopsy Cases, with Particular Reference to Delayed Central Nervous System Myelination , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[4]  A. Hart,et al.  Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. , 1999, Radiology.

[5]  R. Folkerth Abnormalities of developing white matter in lysosomal storage diseases. , 1999, Journal of neuropathology and experimental neurology.

[6]  M. Vanier,et al.  Sphingosylphosphorylcholine in Niemann-Pick Disease Brain: Accumulation in Type A But Not in Type B , 1999, Neurochemical Research.

[7]  M. Taniike,et al.  Murine model of genetic demyelinating disease: The twitcher mouse , 1995, Microscopy research and technique.

[8]  J. Alroy,et al.  Dysmyelinogenesis in animal model of GM1 gangliosidosis. , 1992, Pediatric neurology.

[9]  A. Percy,et al.  Globoid cell leukodystrophy: comparison of neuropathology with magnetic resonance imaging , 2004, Acta Neuropathologica.

[10]  M. S. van der Knaap,et al.  Magnetic resonance in childhood white-matter disorders. , 2001, Developmental medicine and child neurology.